$2.91
0.269.81%
At Close: -
$2.98
0.072.41%
After Hours: 4:24 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Aileron Therapeutics (NASDAQ:ALRN) Stock
Aileron Therapeutics Stock (NASDAQ: ALRN)
Categories: All
Thursday, August 15, 2024
Friday, July 26, 2024
Monday, July 01, 2024
Wednesday, May 15, 2024
Wednesday, May 01, 2024
Thursday, April 18, 2024
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Aileron Therapeutics shares are trading highe...
- Aileron Therapeutics Filed U.S. Patent Application #20240124518: Methods For Preparing Purified Polypeptide Compositions
- Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Ladenburg Thalmann Maintains Buy on Aileron T...
Monday, April 15, 2024
Tuesday, March 12, 2024
Friday, March 01, 2024
Thursday, February 15, 2024
Tuesday, January 30, 2024
Tuesday, January 23, 2024
Friday, January 12, 2024
Friday, December 15, 2023
- Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
Thursday, December 14, 2023
Friday, December 01, 2023
Monday, November 06, 2023
Friday, November 03, 2023
Wednesday, November 01, 2023
Tuesday, October 31, 2023
Wednesday, May 10, 2023
Monday, April 03, 2023
Friday, March 31, 2023
Friday, March 03, 2023
Tuesday, February 21, 2023
- S&P 500 Down 2%; Mobilicom Shares Spike Higher
- Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
- Stocks That Hit 52-Week Lows On Tuesday
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Aileron Therapeutics shares are trading lower...
- Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
- Nasdaq Drops Over 100 Points; Walmart Issues Cautious Forecast
- Aileron Therapeutics Announces Termination Of Phase 1b Breast Cancer Chemoprotection Trial And Exploration Of Strategic Alternatives
- Aileron Therapeutics Shares Halted, News Pend...